Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $9,537 | 1 | 95.5% |
| Food and Beverage | $451.34 | 6 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $9,689 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $162.73 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $90.14 | 1 | $0 (2023) |
| ABBVIE INC. | $46.78 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.85 | 1 | ABBVIE INC. ($34.85) |
| 2023 | $90.14 | 1 | AstraZeneca Pharmaceuticals LP ($90.14) |
| 2022 | $163.62 | 2 | Medtronic, Inc. ($151.69) |
| 2021 | $9,700 | 3 | Medtronic, Inc. ($9,537) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.85 | General |
| Category: FACIAL AESTHETICS | ||||||
| 06/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $90.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2022 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $151.69 | General |
| Category: Drug Infusion Systems | ||||||
| 04/06/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $102.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/25/2021 | Medtronic, Inc. | ASCENDA (Device) | Grant | Cash or cash equivalent | $9,536.86 | General |
| Category: Drug Infusion Systems | ||||||
| 09/15/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $59.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 238 | 309 | $257,676 | $20,182 |
| 2022 | 5 | 78 | 90 | $58,459 | $5,855 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 54 | $13,014 | $3,412 | 26.2% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Facility | 2023 | 15 | 24 | $60,931 | $2,410 | 4.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $16,733 | $2,347 | 14.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $8,295 | $2,028 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 21 | $7,455 | $2,012 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $9,860 | $1,755 | 17.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 17 | $8,296 | $1,522 | 18.3% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2023 | 14 | 19 | $36,119 | $1,107 | 3.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 15 | 15 | $12,750 | $1,089 | 8.5% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2023 | 15 | 23 | $43,723 | $1,013 | 2.3% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 36 | 60 | $30,900 | $799.20 | 2.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 11 | 15 | $9,600 | $686.70 | 7.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $10,640 | $1,589 | 14.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $5,907 | $1,495 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 21 | $4,914 | $1,434 | 29.2% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2022 | 11 | 13 | $23,998 | $962.99 | 4.0% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 22 | 26 | $13,000 | $374.25 | 2.9% |
About Dr. Bindiya Shah, DO
Dr. Bindiya Shah, DO is a Physical Medicine & Rehabilitation healthcare provider based in Milwaukee, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2017. The National Provider Identifier (NPI) number assigned to this provider is 1659809739.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bindiya Shah, DO has received a total of $9,988 in payments from pharmaceutical and medical device companies, with $34.85 received in 2024. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Grant" ($9,537).
As a Medicare-enrolled provider, Shah has provided services to 316 Medicare beneficiaries, totaling 399 services with total Medicare billing of $26,037. Data is available for 2 years (2022–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Milwaukee, WI
- Active Since 06/01/2017
- Last Updated 07/02/2021
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1659809739
Products in Payments
- ASCENDA (Device) $9,537
- XARELTO (Drug) $162.73
- SYNCHROMEDII (Device) $151.69
- FARXIGA (Drug) $90.14
- BOTOX (Biological) $46.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Milwaukee
Dr. Nicholas Ketchum, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $640,689
Mr. Christopher Cronsell, Md, MD
Physical Medicine & Rehabilitation — Payments: $415,633
Dr. John Mcguire, Md, MD
Physical Medicine & Rehabilitation — Payments: $90,251
Dr. Erin Mcgonigle, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $89,504
Dr. Brian Robertson-Dick, Md, MD
Physical Medicine & Rehabilitation — Payments: $69,100
Carla Wright, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $8,127